| ICD10 CODE | ICD 10 | DESCRIPTION | MEDICINE | |||
| SHORT | CODE | NAPPI | GENERIC SUBSTANCE | TRADE NAME | ||
| E78 | E78.0 E78.1 E78.2 E78.3 E78.4 E78.5 | Pure hypercholes- terolaemia Pure hyperglycerid- aemia Mixed hyperlipid- aemia Hyperchylo- micronaemia Other hyperlipid- aemia Hyperlipid- aemia, unspecified | 708453 828300 789127 818518 788627 701276 783951 701279 783978 701281 836265 | BEZAFIBRATE TAB 200 MG BEZAFIBRATE TAB CR 400 MG FENOFIBRATE CAP 300 MG NICOTINIC ACID GEMFIBROZIL TAB 600 MG SIMVASTATIN TAB 10 MG SIMVASTATIN TAB 10 MG SIMVASTATIN TAB 20 MG SIMVASTATIN TAB 20 MG SIMVASTATIN TAB 40 MG SIMVASTATIN TAB 40 MG | BEZALIP 200MG TAB ROLAB-BEZAFIBRATE 400 TBC LIPSIN 300MG CAP NICOTINIC ACID 100MG TAB LOPID 600MG TAB ADCO-SIMVASTATIN 10MG ZOCOR 10MG TAB ADCO-SIMVASTATIN 20MG ZOCOR 20MG TAB ADCO-SIMVASTATIN 40MG ZOCOR 40MG TAB | PMB protocol: 1) If fasting plasma TC < 5mmol/l and no manifest coronary heart disease or other risk factors eg diabetes, smoking, hypertension: Lifestyle modification. Follow up in 5 years 2) If fasting plasma TC < 5mmol/l and manifest coronary heart disease or other risk factors eg diabetes, smoking, hypertension: Do fasting TG, TC, HDLC, LDLC Screen for secondary causes e.g. diabetes, hypothyroidism Secondary hyperlipidaemia: First line: Treat cause, Lifestyle modifications, Modify other risk factors Second line: Utilize Framingham Risk score, if 10Year MI risk >20%, 60 year age risk >30% use statin at lowest dose or fibrate if triglycerides >5 mmol/l 3) If fasting plasma TC > 5mmol/l d Do fasting TG, TC, HDLC, LDLC Screen for secondary causes e.g. diabetes, hypothyroidism Secondary hyperlipideamia : As above Primary hyperlipideamia: Only with genetic dyslipidaemia and LDLC>3 mmol/l and/or established vascular diasease: Treat with statin or fibrate Other cases: Utilize Framingham Risk score, if 10 Year MI risk >20%, 60 year age risk >30% use statin at lowest dose or fibrate if triglycerides >5 mmol/l Target: LDLC < 3 mmol/l or reduction of 45% Follow up 6-12 monthly. |
January 2004